°³ÀÎ ½Äº° ½ÃÀå º¸°í¼ : Á¦Ç° ¹× ¼ºñ½º, ±â¼ú, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªº°(2025-2033³â)
Human Identification Market Report by Product & Service, Technology, Application, End User, and Region 2025-2033
¼¼°è °³ÀÎ ½Äº° ½ÃÀå ±Ô¸ð´Â 2024³â 21¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº 2033³â±îÁö 53¾ï ´Þ·¯¿¡ ´ÞÇϰí, 2025-2033³â 10.17%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» º¸ÀÏ °ÍÀ¸·Î Àü¸ÁÇϰí ÀÖ½À´Ï´Ù. ½ÃÀå °¡Ä¡¸¦ ³ôÀÌ´Â ¿äÀÎÀ¸·Î´Â ÇコÄÉ¾î ¹× °³ÀÎ À¯Àüü¿¡¼ÀÇ »ç¿ë Áõ°¡, ¹üÁËÀ² Áõ°¡, Å×·¯ Ȱµ¿ µî ´Ù¾çÇÑ ¿äÀÎÀÌ ÀÖ½À´Ï´Ù. ÀÌ ¿Ü¿¡µµ Áö¹®ÀνÄ, ¾È¸éÀÎ½Ä µî ÷´Ü ±â¼úÀÇ ÅëÇÕÀÌ ¼öÀÍ Ã¢Ãâ¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.
°³ÀÎ ½Äº°Àº °³ÀÎ ½Äº° ¹× °úÇмö»ç¸¦ À§ÇØ µ¥¿Á½Ã¸®º¸ÇÙ»ê(DNA) »ùÇÃÀ» ºÐ¼®ÇÏ´Â µ¥ »ç¿ëµÇ´Â ±â¼úÀ» ¸»ÇÕ´Ï´Ù. ÀÔ¼ú, ¾ó±¼, ¸Ó¸®, ¸Ó¸®, ¾î±ú, Áö¹®, ¼Õ¹Ù´ÚÀÇ °ËÃâÀ» Áö¿øÇÏ´Â ½Åü ºÎÀ§ °ËÃâ±â·Î ±¸¼ºµË´Ï´Ù. ¶ÇÇÑ Â÷¼¼´ë¿°±â¼¿ºÐ¼®(NGS), ¸ð¼¼°ü Àü±â¿µµ¿, ½Å¼Ó DNA ºÐ¼®, ÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ(PCR), ÇÙ»ê Á¤Á¦, ÃßÃâ ±â¼úµµ Ȱ¿ëÇϰí ÀÖ½À´Ï´Ù. °³ÀÎ ½Äº°Àº ¹üÁËÀÚ ½Äº°, Àΰ£ Ư¡ÀÇ Àü¹ÝÀûÀÎ ºÐ¼®, ½ÇÁ¾ÀÚ ½Äº°, ÀüÀï Èñ»ýÀÚ ½Äº°, ÀçÇØ Èñ»ýÀÚ ½Äº°, »ç¸Á ¿øÀÎ ¹× »ç¸Á ¹æ¹ý ½Äº° µî¿¡ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ °³ÀÎÀÇ ¹üÁË ±â·Ï ÃßÀû, ÈçÀû È®ÀÎ, »ç¸é °áÁ¤¿¡µµ µµ¿òÀÌ µË´Ï´Ù.
°³ÀÎ ½Äº° ½ÃÀå µ¿Çâ :
¼¼°è ¹üÁËÀ² Áõ°¡¿¡ µû¸¥ DNA °¨Á¤¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â Áß¿äÇÑ ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ÀÌ¿¡ µû¶ó °³ÀÎ ½Äº°Àº ¹ýÀÇÇÐ, Àç³ ÇÇÇØÀÚ ½Äº°, ÀηùÇÐ µî¿¡¼ ³Î¸® »ç¿ëµÇ¾î ºÎÁ¤°ú °ü·ÃµÈ Àι°À» ¹èÁ¦ÇÏ°í º¸´Ù ½ÇÇà °¡´ÉÇÑ ¼ö»ç ¼ö´ÜÀ¸·Î ÀÚ¿øÀ» ÀüȯÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀΰøÁö´É(AI)°ú ¸Ó½Å·¯´×(ML)ÀÇ ÅëÇÕ µî ¾ó±¼ Ư¡ ¸ÅÇÎ ¹× ±â·Ï, °íǰÁú ¼Ò½º »ùÇà ȹµæ, ½Ã½ºÅÛ È¿À²¼º °³¼± µîÀ» Áö¿øÇÏ´Â ´Ù¾çÇÑ ±â¼ú ¹ßÀüÀÌ ½ÃÀå ¼ºÀå¿¡ ź·ÂÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½ÃÄö½Ì ±â¼úÀÇ ÃÖ±Ù µ¿ÇâÀº ¹ýÀÇÇÐ ¹× Ä£ÀÚÈ®ÀÎ ½ÇÇè½Ç¿¡¼ ¸ð¼¼°ü Àü±â¿µµ¿(CE) ¹× Ãʺ´·Ä ½ÃÄö½Ì(MPS) ¹æ¹ýÀÇ È°¿ëÀ» °ÈÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå ¼ºÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. À̿ʹ º°µµ·Î, ±¤¹üÀ§ÇÑ ¿¬±¸°³¹ß(R&D) Ȱµ¿°ú ¹ýÀÇÇÐ ÇÁ·Î±×·¥¿¡ ÀÚ±ÝÀ» Áö¿øÇϱâ À§ÇÑ ´Ù¾çÇÑ Á¤ºÎ Á¤Ã¥ÀÇ ½ÃÇàÀº ½ÃÀå Àü¸ÁÀ» ¹à°Ô Çϰí ÀÖ½À´Ï´Ù.
º» º¸°í¼¿¡¼ ´Ù·é ÁÖ¿ä Áú¹®
- °³ÀÎ ½Äº° ½ÃÀå ±Ô¸ð´Â?
- °³ÀÎ ½Äº° ½ÃÀå Àü¸ÁÀº?
- °³ÀÎ ½Äº° ½ÃÀåÀ» À̲ô´Â ÁÖ¿ä ¿äÀÎÀº?
- °³ÀÎ ½Äº° ½ÃÀå¿¡¼ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÏ´Â Áö¿ªÀº?
- ¼¼°è °³ÀÎ ½Äº° ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº?
¸ñÂ÷
Á¦1Àå ¼¹®
Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý
- Á¶»ç ¸ñÀû
- ÀÌÇØ°ü°èÀÚ
- µ¥ÀÌÅÍ ¼Ò½º
- ½ÃÀå ÃßÁ¤
- Á¶»ç ¹æ¹ý
Á¦3Àå ÁÖ¿ä ¿ä¾à
Á¦4Àå ¼·Ð
Á¦5Àå ¼¼°èÀÇ °³ÀÎ ½Äº° ½ÃÀå
- ½ÃÀå °³¿ä
- ½ÃÀå ½ÇÀû
- COVID-19ÀÇ ¿µÇâ
- ½ÃÀå ¿¹Ãø
Á¦6Àå ½ÃÀå ºÐ¼® : Á¦Ç° ¹× ¼ºñ½ºº°
- ±â±â
- ¾î¼¼ÀÌ Å°Æ® ¹× ½Ã¾à
- ¼ÒÇÁÆ®¿þ¾î ¹× ¼ºñ½º
Á¦7Àå ½ÃÀå ºÐ¼® : ±â¼úº°
- ÁßÇÕÈ¿¼Ò ¿¬¼â¹ÝÀÀ(PCR)
- Â÷¼¼´ë ½ÃÄö½Ì(NGS)
- ÇÙ»ê Á¤Á¦ ¹× ÃßÃâ
- ¸ð¼¼°ü Àü±â¿µµ¿
- ½Å¼Ó DNA ºÐ¼®
- ±âŸ
Á¦8Àå ½ÃÀå ºÐ¼® : ¿ëµµº°
Á¦9Àå ½ÃÀå ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°
- ¹ýÀÇÇÐ ¿¬±¸¼Ò
- ¿¬±¸¼¾ÅÍ, Çмú±â°ü ¹× Á¤ºÎ±â°ü
Á¦10Àå ½ÃÀå ºÐ¼® : Áö¿ªº°
- ºÏ¹Ì
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- Áß±¹
- ÀϺ»
- Àεµ
- Çѱ¹
- È£ÁÖ
- Àεµ³×½Ã¾Æ
- ±âŸ
- À¯·´
- µ¶ÀÏ
- ÇÁ¶û½º
- ¿µ±¹
- ÀÌÅ»¸®¾Æ
- ½ºÆäÀÎ
- ·¯½Ã¾Æ
- ±âŸ
- ¶óƾ¾Æ¸Þ¸®Ä«
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
Á¦11Àå SWOT ºÐ¼®
Á¦12Àå ¹ë·ùüÀÎ ºÐ¼®
Á¦13Àå PorterÀÇ Five Forces ºÐ¼®
- °³¿ä
- ¹ÙÀ̾îÀÇ ±³¼··Â
- °ø±Þ ±â¾÷ÀÇ ±³¼··Â
- °æÀï Á¤µµ
- ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
- ´ëüǰÀÇ À§Çù
Á¦14Àå °¡°Ý ºÐ¼®
Á¦15Àå °æÀï ±¸µµ
- ½ÃÀå ±¸Á¶
- ÁÖ¿ä ±â¾÷
- ÁÖ¿ä ±â¾÷ °³¿ä
- Abbott Laboratories
- Agilent Technologies Inc.
- Bio-Rad Laboratories Inc.
- Eurofins Scientific
- Hamilton Company
- Illumina Inc.
- Laboratory Corporation of America Holdings
- PerkinElmer Inc.
- Promega Corporation
- Qiagen N.V.
- Siemens AG
- Thermo Fisher Scientific Inc.
LSH
The global human identification market size reached USD 2.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.3 Billion by 2033, exhibiting a growth rate (CAGR) of 10.17% during 2025-2033. There are various factors that are adding value to the market, which include rising applications in healthcare and personal genomics, increasing crime rates and terrorism activities. Besides this, integration of advanced technologies such as fingerprinting and facial recognition is assisting in generating revenue.
Human identification refers to a technique used to analyze the deoxyribonucleic acid (DNA) sample for the identification of individuals and forensic investigation. It consists of body part detectors that assist in detecting lips, face, heads, shoulders, fingerprints, and palms. It also utilizes next-generation sequencing (NGS), capillary electrophoresis, rapid DNA analysis, polymerase chain reaction (PCR), nucleic acid purification, and extraction technologies. Human identification is widely used for criminal identification, overall analytics of human traits, identifying missing persons, casualties of war, disaster victims, and cause and manner of death. It also assists in tracking individual criminal record, identifying traces, and pardoning decisions.
Human Identification Market Trends:
The increasing demand for DNA analysis on account of rising criminal rates across the globe is one of the key factors driving the growth of the market. In line with this, human identification is widely used in forensics, disaster victim identification, and anthropology for eliminating wrongly associated individuals and redirecting resources to more viable avenues of investigation. Moreover, various technological advancements, such as the integration of artificial intelligence (AI) and machine learning (ML), that assists in mapping and recording facial features, obtaining high-quality source samples, and improving system efficiency, are providing an impetus to the market growth. Additionally, recent developments in sequencing technology have enhanced the utilization of capillary electrophoresis (CE) and massively parallel sequencing (MPS) methods for human identification in forensic and paternity testing labs, which, in turn, is positively impacting the market growth. Apart from this, extensive research and development (R&D) activities and the implementation of various government policies to provide funding for forensic programs are creating a positive outlook for the market.
Key Market Segmentation:
Breakup by Product & Service:
- Instruments
- Assay Kits and Reagents
- Software and Services
Breakup by Technology:
- Polymerase Chain Reaction (PCR)
- Next Generation Sequencing (NGS)
- Nucleic Acid Purification and Extraction
- Capillary Electrophoresis
- Rapid DNA Analysis
- Others
Breakup by Application:
- Forensic Applications
- Paternity Testing
- Others
Breakup by End User:
- Forensic Laboratories
- Research Centers, Academic and Government Institutes
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Eurofins Scientific, Hamilton Company, Illumina Inc., Laboratory Corporation of America Holdings, PerkinElmer Inc., Promega Corporation, Qiagen N.V., Siemens AG and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report
- 1.How big is the human identification market?
- 2.What is the future outlook of human identification market?
- 3.What are the key factors driving the human identification market?
- 4.Which region accounts for the largest human identification market share?
- 5.Which are the leading companies in the global human identification market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Human Identification Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product & Service
- 6.1 Instruments
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Assay Kits and Reagents
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Software and Services
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Technology
- 7.1 Polymerase Chain Reaction (PCR)
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Next Generation Sequencing (NGS)
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Nucleic Acid Purification and Extraction
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Capillary Electrophoresis
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Rapid DNA Analysis
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
- 7.6 Others
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
8 Market Breakup by Application
- 8.1 Forensic Applications
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Paternity Testing
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Others
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by End User
- 9.1 Forensic Laboratories
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Research Centers, Academic and Government Institutes
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Abbott Laboratories
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 Financials
- 15.3.1.4 SWOT Analysis
- 15.3.2 Agilent Technologies Inc.
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.2.3 Financials
- 15.3.2.4 SWOT Analysis
- 15.3.3 Bio-Rad Laboratories Inc.
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.3.4 SWOT Analysis
- 15.3.4 Eurofins Scientific
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.4.3 Financials
- 15.3.4.4 SWOT Analysis
- 15.3.5 Hamilton Company
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.6 Illumina Inc.
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.6.3 Financials
- 15.3.6.4 SWOT Analysis
- 15.3.7 Laboratory Corporation of America Holdings
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.7.3 Financials
- 15.3.7.4 SWOT Analysis
- 15.3.8 PerkinElmer Inc.
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.8.3 Financials
- 15.3.8.4 SWOT Analysis
- 15.3.9 Promega Corporation
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.10 Qiagen N.V.
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.10.3 Financials
- 15.3.10.4 SWOT Analysis
- 15.3.11 Siemens AG
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
- 15.3.11.3 Financials
- 15.3.11.4 SWOT Analysis
- 15.3.12 Thermo Fisher Scientific Inc.
- 15.3.12.1 Company Overview
- 15.3.12.2 Product Portfolio
- 15.3.12.3 Financials
- 15.3.12.4 SWOT Analysis